Coronavirus disease 2019 (COVID-19) is an emerging infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). First reported at the end of December 2019 as a cause for clusters of pneumonia cases in Wuhan city in China, the rapid spread of this condition was declared a pandemic on March 11, 2020, by the World Health Organization (WHO). Apart from the mortality and morbidity associated with COVID-19, the massive social and financial havoc inflicted by this pandemic has left the entire world pondering if medical science can innovate and curtail the ongoing damage due to SARS-CoV-2. Recent findings of an open-label study that investigated the use of hydroxychloroquine and azithromycin in COVID-19 patients in Marseille, France, has garnered some optimism in scientific quarters and the general public alike in terms of finding a treatment regimen to control the rampant rise of COVID-19. We will discuss the potential off-label therapy and studies as it pertains to COVID-19.
【저자키워드】 coronavirus disease, Azithromycin, Hydroxychloroquine, sars-cov-2 (severe acute respiratory syndrome coronavirus -2), 【초록키워드】 COVID-19, SARS-CoV-2, Coronavirus disease 2019, coronavirus, pandemic, therapy, Mortality, Open-label, Infectious disease, Spread, China, morbidity, Cluster, France, WHO, Marseille, COVID-19 patient, World Health Organization, optimism, acute respiratory syndrome, treatment regimen, off-label, recent, caused, reported, investigated, curtail, pneumonia case, use of hydroxychloroquine, with COVID-19, 【제목키워드】 LIGHT, End,